Skip to main content
Caplight Logo









Hangzhou Calibra Diagnostics Co., Ltd.

Hangzhou Calibra Diagnostics Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttps://calibradx.com/

Last Round

Series C

Extension

Dec 27, 2022

Total Funding Raised

$65.08M

Company Overview

Hangzhou Calibra Diagnostics Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. Its latest recorded funding round was a Series C Extension round in December 2022.

Hangzhou Calibra Diagnostics Co., Ltd. is a biotechnology company that provides clinical mass spectrometry solutions, reagents, consumables, and laboratory services for precision medicine and multi-omics research.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Usage-Based SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Hangzhou Calibra Diagnostics Co., Ltd. Comparables

Compare Hangzhou Calibra Diagnostics Co., Ltd. with similar companies based on industry and business-model similarity.

Hangzhou Calibra Diagnostics Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shandong Yingsheng Biotechnology Co., Ltd.
87%
Hangzhou Well-healthcare Technologies Co., Ltd.
86%
Shanghai Reigncom Biotech Co., Ltd.
85%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Hangzhou Calibra Diagnostics Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series C ExtensionDec 27, 2022
Series CMay 5, 2022
Series BFeb 24, 2021
Series ASep 1, 2020
AngelDec 1, 2016
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Huafen Liu

Founder and CEO

Founding Team

For institutional investors. Book with your work email.

Hangzhou Calibra Diagnostics Co., Ltd. Investors

Notable investors and investment history

Hangzhou Calibra Diagnostics Co., Ltd. investors
InvestorRounds
Boyuan CapitalSeries A
Delian CapitalSeries B
松禾资本 (Green Pine Capital Partners)Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 21, 2026

    Monthly visitors increased 521% MoM, reaching 6.1K.

  • Dec 27, 2022

    Raised $4.29M in Series C Extension funding.

Book a demo to see all signals

For institutional investors. Book with your work email.

Hangzhou Calibra Diagnostics Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Hangzhou Calibra Diagnostics Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Hangzhou Calibra Diagnostics Co., Ltd.'s valuation, stock price, and market status.

Is Hangzhou Calibra Diagnostics Co., Ltd. a public or private company?

Hangzhou Calibra Diagnostics Co., Ltd. is a private company.

What is the current stock price of Hangzhou Calibra Diagnostics Co., Ltd.?

Hangzhou Calibra Diagnostics Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hangzhou Calibra Diagnostics Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Hangzhou Calibra Diagnostics Co., Ltd. worth (valuation)?

Valuation information for Hangzhou Calibra Diagnostics Co., Ltd. is not publicly available.

Can I buy Hangzhou Calibra Diagnostics Co., Ltd. stock?

Hangzhou Calibra Diagnostics Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Hangzhou Calibra Diagnostics Co., Ltd.'s last funding round?

Hangzhou Calibra Diagnostics Co., Ltd.'s most recent funding round was Series C Extension on December 27, 2022.

Who are the main investors in Hangzhou Calibra Diagnostics Co., Ltd.?

Key investors in Hangzhou Calibra Diagnostics Co., Ltd. include Boyuan Capital.

Will Hangzhou Calibra Diagnostics Co., Ltd. IPO soon?

No public IPO plans have been announced for Hangzhou Calibra Diagnostics Co., Ltd..

How can I track Hangzhou Calibra Diagnostics Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades in Hangzhou Calibra Diagnostics Co., Ltd.'s shares on secondary markets.

Firmographic Details

HeadquartersHangzhou
Employee Range6
Year Founded2016
Last FundingDec 27, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?